The development of multidrug resistance is often associated with the over-expression of
P-glycoprotein (P-gp). This
protein prevents
drug accumulation and extrudes them out of the cell before they reach the intended target. The aim of this study was to develop an in vitro MCF-7 cell line with increased expression of P-gp and test the
phototoxicity of a novel photoactivated
zinc phthalocyanine tetrasulfonic
acid (
ZnPcS4) on these cells. The over-expressed P-gp MCF-7 cells (MCF-7/DOX) were developed from wildtype (WT) MCF-7 cells by a stepwise continuous exposure of the WT cells to different concentrations of
Doxorubicin (DOX) (0.1 - 1 μM) over a period of 4 months. The P-gp expression was measured using flow cytometry, immunofluorescence and
enzyme immunoassay. To verify whether
zinc phthalocyanine-mediated
photodynamic therapy (
ZnPcS4 -
PDT) is effective in MCF-7/DOX, we studied the subcellular localization,
phototoxicity and nuclear damage. The flow cytometry result showed two distinct peaks of P-gp positive and negative expression in MCF-7/DOX cell population, which correlates with the ELISA-based assay (p˂0.001). The ME16C (Normal breast cells) was used as control. The localization studies showed that
ZnPcS4 have greater affinity for lysosome than mitochondria.
Phototoxicity results indicated that photoactivated
zinc phthalocyanine decreased the cell proliferation and viability as the
drug and
laser light dosages increased to 16 μM and 20 J/cm2 respectively.
PDT-induced cytotoxicity using
lactose dehydrogenase (LDH)
enzyme leakage as measure did not increase likewise. The ZnPcS4-induced
PDT was less effective for MCF-7/DOX cells which could be attributed to decreased retention of
ZnPcS4 in major cellular organelles due to the presence of increased
drug efflux P-gp. The current findings suggest that, increased P-gp expression, a characteristic of multidrug resistance together with other related intrinsic mechanisms might contribute to render MCF-7/DOX cells less sensitive to ZnPcS4-induced
phototoxicity.